Danaher Corporation (NYSE:DHR) Q1 2024 Earnings Call Transcript

Rainer Blair: Rachel, we actually don’t break it down in terms of how we guide for a quarter or a full year between consumables and equipment. We stay at the top level and as we pointed out, we were happy to see the sequential growth here in the first quarter of 5% and what I can say is that the recurring revenue represents about 85% of bioprocessing. And of course, that was also the major driver of the improvement in orders that you saw and the book-to-bill in the quarter and of course, that’s where our focus was, is that’s where the destocking was taking place here over the prior quarters. So if you think about our guide here for the full year for bioprocessing, down low-single digits, 85% of the business is recurring and roughly 15% is equipment. I think that’s the best way to think about that in terms of our guide and how that split.

Operator: Thank you. At this time, I would like to turn the call back over to John Bedford for any additional or closing remarks.

John Bedford: Thank you, everyone, for joining us today. We’ll be around all day and rest of the week for follow-ups. Have a good day.

Rainer Blair: Thanks, everyone.

Operator: This does conclude Danaher’s first quarter 2024 earnings conference call. You may disconnect your line at this time, and have a wonderful day.